Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Fresh Perspective for BIO Operations,…
Washington, D.C.  – As the Biotechnology Innovation Organization (BIO) continues to restructure for a stronger and reinvigorated future, the organization announced new leadership for operations and sustainability. Shaye Mandle was named Chief…
Supercharging Marketing—the Mission for New Chief…
Washington, DC – The Biotechnology Innovation Organization (BIO) has appointed Melissa von Stauffenberg as Chief Marketing Officer, effective February 1, 2021. The newly created position emerged from a recent reorganization aimed at driving a…
New “100 Days of Innovation” Blueprint Outlines…
As Congress and the new President lay out their aggressive “100 Day Plans,” The Biotechnology Innovation Organization (BIO) today released a new blueprint highlighting goals to strengthen America’s innovation ecosystem, end the COVID-19 pandemic,…
All Press Releases
  • Show All
Search
February 16, 2021
Washington, D.C.  – As the Biotechnology Innovation Organization (BIO) continues to restructure for a stronger and reinvigorated future, the organization announced new leadership for operations and sustainability. Shaye Mandle was named Chief…
January 28, 2021
Washington, DC – The Biotechnology Innovation Organization (BIO) has appointed Melissa von Stauffenberg as Chief Marketing Officer, effective February 1, 2021. The newly created position emerged from a recent reorganization aimed at driving a…
January 27, 2021
As Congress and the new President lay out their aggressive “100 Day Plans,” The Biotechnology Innovation Organization (BIO) today released a new blueprint highlighting goals to strengthen America’s innovation ecosystem, end the COVID-19 pandemic,…
January 27, 2021
The Biotechnology Innovation Organization announced today that it will resume political giving under new criteria for political leaders seeking campaign assistance. Shortly after the violent demonstration three weeks ago at the US Capitol BIO…
January 21, 2021
The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…
January 21, 2021
Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…
January 20, 2021
In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…
January 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office:  “On behalf of the Biotechnology…
January 19, 2021
Washington, DC –  The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…
January 16, 2021
President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.